Jun 01, 2020
Varian Appoints Michael Hutchinson to Senior Vice President, Chief Legal Officer, and Francis R. Facchini, M.D., FSIR to President, Interventional Solutions Business
May 29, 2020
Varian to Participate in Goldman Sachs Global Virtual Healthcare Conference
May 27, 2020
Varian to Participate in Jefferies Virtual Healthcare Conference
May 21, 2020
Varian Launches New Noona® Capabilities to Meet Growing Demand for Remote Cancer Patient Monitoring in Response to COVID-19's Impact on Healthcare
May 18, 2020
Varian Announces New Addition to FlashForward Consortium
May 07, 2020
Center in Singapore Expanding Access to Radiation Therapy Technology in the Fight Against Cancer
May 04, 2020
Varian Reports Results for Second Quarter of Fiscal Year 2020; Withdraws 2020 Guidance
Apr 17, 2020
Varian Announces Second Quarter Fiscal Year 2020 Earnings Release Date
Mar 17, 2020
Alabama's Only Proton Therapy Center Treats First Patient with Varian ProBeam
Mar 16, 2020
Varian Halcyon 2.0 Treatment System Receives China NMPA Approval
Mar 11, 2020
Quebec Selects Varian to Increase Access to Advanced Cancer Care
Mar 10, 2020
Ethos Therapy Continues Global Expansion
Mar 09, 2020
Varian Provides an Update on Expected Impact From COVID-19
Feb 27, 2020
Varian to Attend Upcoming Investor Events
Feb 11, 2020
Varian Receives FDA 510(k) Clearance for Ethos Therapy
Jan 20, 2020
Varian Appoints Prof. Dr. Ricky Sharma VP of Clinical Affairs
Dec 30, 2019
Varian to Present at the J.P. Morgan Healthcare Conference
Dec 18, 2019
Varian Announces First Quarter Fiscal Year 2020 Earnings Release Date
Dec 05, 2019
Varian Schedules Annual Stockholder Meeting in Palo Alto
Nov 27, 2019
Dr. Michelle Le Beau Named to Varian Board of Directors